Yves Koch is a seasoned professional in market access and pricing within the pharmaceutical industry, currently serving as the Director of Global Access Strategy & Pricing Oncology at Pfizer since January 2024. Prior experiences include leadership roles at Seagen, where Koch was the Director of Value Access and Pricing for DACH and later for International markets, focusing on price strategy, HTA submissions, and negotiations. Koch held significant positions at Otsuka Pharmaceutical, directing market access in Switzerland and Austria and leading teams in the D/A/CH region. Previous roles encompass key account management at GlaxoSmithKline and market access management at AbbVie. Academic credentials include a Bachelor of Applied Science in Health Management from the University of Fulda.
This person is not in the org chart
This person is not in any teams
This person is not in any offices